MultiPlan Price Target Cut to $1.00/Share From $2.00 by Piper Sandler

Dow JonesAug 7 08:50 ET · Ratings

MultiPlan Analyst Ratings

BenzingaAug 7 08:39 ET · Ratings

Analysts Conflicted on These Healthcare Names: Nyxoah (NYXH), MultiPlan (MPLN) and Beam Therapeutics (BEAM)

TipRanksAug 7 07:01 ET · Ratings

MultiPlan Earns 2024 Great Place to Work Certification

BusinesswireAug 6 14:00 ET

Grant of Awards to New MultiPlan Executive Officers Under NYSE Listing Rules

Yahoo FinanceAug 5 19:21 ET

10-Q: Q2 2024 Earnings Report

SEC announcementAug 2 07:29 ET · Announcements